Location: Gloucester
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Gloucester
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) Phase 3 · Gloucestershire Royal Hospital · Boehringer Ingelheim · NCT06531824 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Addison Gilbert Hospital · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · Addison Gilbert Hospital · Alliance for Clinical Trials in Oncology · NCT06632327 E-Mindfulness Approaches for Living After Breast Cancer Phase 3 · Addison Gilbert Hospital · NRG Oncology · NCT06748222 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab Phase 2 · Addison Gilbert Hospital · NRG Oncology · NCT05327686 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study NA · Gloucestershire Hospitals NHS Foundation · University of Leicester · NCT04204915 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT06058377 An Internet-based Program to Help Cancer Survivors Manage Pain NA · Peninsula Cancer Institute - Gloucester · Wake Forest University Health Sciences · NCT04462302 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo Phase 2/Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT05987241 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Phase 3 · Peninsula Cancer Institute-Gloucester · Alliance for Clinical Trials in Oncology · NCT05008848 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Phase 2/Phase 3 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT06616584 A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema Phase 2 · Gloucestershire Royal Hospital · Boehringer Ingelheim · NCT06962839 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f Phase 3 · Gloucestershire Royal Hospital · Belfast Health and Social Care Trust · NCT06985706 Randomised Evaluation of Sodium Dialysate Levels on Vascular Events Phase 4 · Cotswold Dialysis Centre · University of Sydney · NCT02823821 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer Phase 2/Phase 3 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT03851445 WithHolding Enteral Feeds Around Blood Transfusion (International) NA · Gloucestershire Hospitals NHS Foundation Trust (Gloucestersh · IWK Health Centre · NCT05213806 A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Phase N/A · Gloucestershire Royal Hospital · Complement Therapeutics · NCT07144137 Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer Phase 3 · Addison Gilbert Hospital · Canadian Cancer Trials Group · NCT06205485 Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT04181060 Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Va Phase 4 · Clinical Trial Unit, Dep. Ophth., Gloucestershire Hospitals · Association for Innovation and Biomedical Research on Light · NCT06709339 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-M Phase 2 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT06116682 Hydrolysed Rice Formula Study NA · Gloucestershire Royal NHS Trust · Nutricia UK Ltd · NCT06288503 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Phase 3 · Gloucester Royal Hospital · UMC Utrecht · NCT02735707 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever Phase 3 · Gloucestershire Royal Hospital /ID# 257953 · AbbVie · NCT06012240 A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588 Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors Phase N/A · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT04871542 Optimisation of the Blood Culture Pathway Utilising Behaviour Change Phase N/A · Gloucestershire Royal Hospital · Gloucestershire Hospitals NHS Foundation Trust · NCT07392684 A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma Phase 3 · Gloucestershire Royal Hospital · Takeda · NCT06980480
Look up another city
Look up another condition